Trial site
Hospital Ernesto Dornelles
- 16running trials
- 8closed trials
The trials here
What the 24 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis5 trials
- Lung cancer4 trials
- Atopic dermatitis (eczema)2 trials
- Atrial fibrillation2 trials
- Crohn's disease2 trials
- Prostate cancer2 trials
- Coronary artery disease1 trial
- Gastric and oesophageal cancer1 trial
- Idiopathic pulmonary fibrosis1 trial
- Kidney cancer1 trial
- Liver and biliary tract cancer1 trial
- Melanoma1 trial
- and 2 more
- Phase
- Phase 313 trials
- Phase 26 trials
- Phase 2/32 trials
- Status
- Active, not recruiting8 trials
- Recruiting8 trials
- Completed5 trials
- Terminated3 trials
- Lead sponsor
- Janssen Research & Development, LLC9 trials
- Daiichi Sankyo3 trials
- Amgen2 trials
- Eli Lilly and Company2 trials
- Genentech, Inc.1 trial
- and 7 more
Running trials
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Recruiting
Recruiting
Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Recruiting
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ulcerative colitis4 recruiting
- Crohn's disease2 recruiting
- Atrial fibrillation1 recruiting
- Lung cancer1 recruiting
- Stroke1 recruiting
Closed trials
Terminated
Completed
Terminated
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Completed
Completed
A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)
Terminated
Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections
Site data: ClinicalTrials.govUpdated 17 Nov 2026